• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OFIZER CONSUMER HEALTH CARE THERMACARE MENSTRUAL; DISPOSABLE PACK, HOT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OFIZER CONSUMER HEALTH CARE THERMACARE MENSTRUAL; DISPOSABLE PACK, HOT Back to Search Results
Lot Number L44886
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Erythema (1840); Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Nausea (1970); Nerve Damage (1979); Hot Flashes/Flushes (2153)
Event Date 06/01/2015
Event Type  Other  
Event Description
A severe allergic reaction [hypersensitivity], full body redness [generalised erythema], heat [feeling hot], itchiness/itchy [pruritus], nauseous [nausea], issues with circulation/nerve damage [nerve injury].Case description: this is a spontaneous report from a contactable consumer.A female patient of an unspecified age and ethnicity started to receive thermacare heatwrap (thermacare menstrual) via an unspecified route of administration from an unspecified date for an unspecified indication.The patient's medical history and concomitant medications were not reported.The patient purchased the product on (b)(6) 2015 and she placed one on in the evening for 2-3 hours and another one later that night for 2-3 hours.She used as directed and she woke up to a full body redness, heat and itchiness.She was then nauseous and continued to stay red, hot and itchy through saturday and sunday.On (b)(6) 2015,.She decided to call into work and went early to an urgent care clinic.The doctor there told her she more than likely had a severe allergic reaction to this product (because the redness started on her belly and hands and spread through saturday and sunday to my entire body).She received a steroid shot right away and two prescriptions, including another steroid.She ended up having to go back to (b)(6) 2015, because she was having issues with circulation, the doctor explained this was an after effect of the severe allergic reaction she received and that there was nerve damage, but would get better with time and to be "patient".Action taken with the product was unknown.Clinical outcome of the events was unknown.Additional information has been requested and will be provided as it becomes available.
 
Manufacturer Narrative
Company clinical evaluation comment/case comment: based on the information provided, the events severe allergic reaction, generalized erythema, pruritus, feeling hot, nausea, and nerve injury are assessed as associated with the device use.This case meets (b)(6) and 30-day fda reportability.
 
Manufacturer Narrative
Follow-up (june 30, 2015): new information received from a contactable consumer includes: patient details, lot number, suspect product indication, suspect product start/stop date, action taken with suspect product, additional event of hands peeling, event onset date, event recovery date and event outcome.Company clinical evaluation comment: based on the information provided, the events severe allergic reaction, generalized erythema, pruritus, skin exfoliation, feeling hot, nausea, and nerve injury are assessed as associated with the device use.This case meets follow up 10-day eu and 30-day fda reportability.
 
Event Description
Hands are peeling terribly (skin exfoliation).
 
Manufacturer Narrative
No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.After a review of the batch thermal records, thermal results all met product release criteria.Consumer alleges burn from wrap.The cause of the alleged burn is inconclusive since review of records does not provide evidence to support defective product.Care should be taken to use the device as it was designed, following all safety and use information as provided with the wrap to avoid the risks of burns or other skin irritations.The product effect may vary with each individual.
 
Event Description
Case description: this is a spontaneous report from a contactable consumer.A (b)(6) female patient of an unspecified ethnicity started to receive thermacare heatwrap (thermacare menstrual) (lot #: l44886, expiration date: feb2018) from an unspecified date in (b)(6) 2015 for menstrual cramps.The patient's medical history and concomitant medications were not reported.The patient purchased the product on (b)(6) 2015 and placed a heatwrap on in the evening for 2-3 hours and another one on later that night for 2 to 3 hours.She used as directed and she woke up to a full body redness, heat and itchiness.She was then nauseous and continued to stay red, hot and itchy through saturday and sunday.On (b)(6) 2015, she decided to call into work and went early to an urgent care clinic.The doctor there told her she more than likely had a severe allergic reaction to this product (because the redness started on her belly and hands and spread through saturday and sunday to entire body).She received an unspecified steroid shot right away and 2 prescriptions, including another steroid.She ended up having to go back to the urgent care clinic on (b)(6) 2015, because she was having issues with circulation.The doctor explained this was an after effect of the severe allergic reaction she received and that there was nerve damage, but would get better with time and to be "patient".The patient reported on an unspecified date in (b)(6) 2015, her hands were peeling.Action taken with the product was permanently withdrawn on an unspecified date in (b)(6) 2015.Therapeutic measures received included an unspecified steroid shot and 2 prescriptions, including another steroid.Clinical outcome of the event hands peeling was not resolved.Clinical outcome of nerve damage was resolving.Clinical outcome of the other events was resolved on an unspecified date in (b)(6) 2015.According to the product quality complaint group: no quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.After a review of the batch thermal records, thermal results all met product release criteria.Consumer alleges burn from wrap.The cause of the alleged burn is inconclusive since review of records does not provide evidence to support defective product.Care should be taken to use the device as it was designed, following all safety and use information as provided with the wrap to avoid the risks of burns or other skin irritations.The product effect may vary with each individual.Additional information has been requested and will be provided as it becomes available.Company clinical evaluation comment: based on the information provided, the events severe allergic reaction, generalized erythema, pruritus, feeling hot, nausea, and nerve injury are assessed as associated with the device use.This case meets initial 10-day eu and 30-day fda reportability.Follow-up (30jun2015): new information received from a contactable consumer includes: patient details, lot number, suspect product indication, suspect product start/stop date, action taken with suspect product, additional event of hands peeling, event onset date, event recovery date and event outcome.Follow-up attempts completed.No further information expected.Follow-up (19aug2015): new information received from the product quality complaint group included investigational results.Follow-up attempts completed.No further information expected.Company clinical evaluation comment: based on the information provided, the events severe allergic reaction, generalized erythema, pruritus, skin exfoliation, feeling hot, nausea, and nerve injury are assessed as associated with the device use.This case meets final 10-day eu and 30-day fda reportability.Case comment: based on the information provided, the events severe allergic reaction, generalized erythema, pruritus, skin exfoliation, feeling hot, nausea, and nerve injury are assessed as associated with the device use.This case meets final 10-day eu and 30-day fda reportability.Evaluation summary: no quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.After a review of the batch thermal records, thermal results all met product release criteria.Consumer alleges burn from wrap.The cause of the alleged burn is inconclusive since review of records does not provide evidence to support defective product.Care should be taken to use the device as it was designed, following all safety and use information as provided with the wrap to avoid the risks of burns or other skin irritations.The product effect may vary with each individual.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE MENSTRUAL
Type of Device
DISPOSABLE PACK, HOT
Manufacturer (Section D)
OFIZER CONSUMER HEALTH CARE
albany GA
Manufacturer (Section G)
PFIZER CONSUMER HEALTH CARE
1231 wyandotte dr.
albany GA 31705
Manufacturer Contact
219 east 42nd st.
new york, NY 10017
2127335544
MDR Report Key4865669
MDR Text Key6042466
Report Number1066015-2015-00073
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
PMA/PMN Number
K953442
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Type of Report Initial,Followup,Followup
Report Date 06/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/01/2018
Device Lot NumberL44886
Initial Date Manufacturer Received 06/10/2015
Initial Date FDA Received06/22/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received07/08/2015
09/03/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age25 YR
-
-